After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Alphabet Inc.'s (NASDAQ: GOOG) Google Cloud introduced two new AI-powered tools that hold the potential to revolutionize the drug development process for biotech and pharmaceutical companies.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

The company was spun out of Google DeepMind in 2021, and is built on the breakthrough AlphaFold system, an AI model that ...

Big Pharma companies are largely spearheading investment in the expansion of AI in drug development, but large tech firms, including Google, and many start-ups, are also cashing in with their own ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery by leveraging AI and proprietary biological data, offering affordable ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.

Pharmaceutical company Servier has selected Google Cloud for its "digital transformation" as it aims to use high-performance computing and artificial intelligence to further its data analysis and ...